SCHEMBL7449092

SCHEMBL7449092

COc1[c]nc2ccccc2c1-c1ncccn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
MAPT P10636 4/20 0.37
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
POLB P06746 2/20 0.36
ABCB1 P08183 2/20 0.36
ABCG2 Q9UNQ0 2/20 0.36
CLK4 Q9HAZ1 3/20 0.35
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 3/20 0.33
CYP2D6 P10635 3/20 0.33
HTT P42858 3/20 0.33
CYP2C19 P33261 2/20 0.33
USP2 O75604 2/20 0.33
LMNA P02545 2/20 0.33
ALOX15 P16050 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7111055 0.86 MAPT (0.45) ALDH1A1MAPTGAANPSR1POLB
SCHEMBL7114136 0.79 BRD4 (0.37) POLBHTT
SCHEMBL7108698 0.79 RAB9A (0.38) POLBCYP1A2NPC1RAB9A
SCHEMBL7112453 0.79 CYP3A4 (0.39) ALDH1A1MAPTGAANPSR1POLB
SCHEMBL9163042 0.75 POLB (0.55) ALDH1A1MAPTPOLBCYP1A2CYP2C19
SCHEMBL558393 0.75 POLB (0.41) ALDH1A1MAPTPOLBCYP1A2CYP3A4
SCHEMBL7455270 0.75 KDM4E (0.40) ALDH1A1MAPTPOLBABCB1ABCG2
SCHEMBL577568 0.69 CCR4 (0.36) POLB
SCHEMBL577493 0.69 MPO (0.30)
SCHEMBL7111069 0.69 ALDH1A1 (0.39) ALDH1A1MAPTGAANPSR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019534-A1 Gem substituted hydroxamic acids PFIZER INC. 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019534-A1 Gem substituted hydroxamic acids MMP14, TOP2A, ADAMTS1 ALDH1A1 1443/4885MAPT 2469/4885GAA 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.